Printer Friendly

MILES INC. AND RHONE-POULENC RORER SETTLE PATENT DISPUTE

 COLLEGEVILLE, Pa. and PITTSBURGH, Jan. 28 /PRNewswire/ -- Miles Inc. and Rhone-Poulenc Rorer Inc. (NYSE: RPR) announced today an agreement to settle an outstanding patent dispute concerning recombinant Factor VIII, which is used to prevent and control bleeding in people with Factor VIII deficiency, also known as hemophilia A.
 The terms of the agreement were not disclosed.
 Miles Inc. is a chemicals, health care and imaging technologies company based in Pittsburgh with its parent company in Germany.
 Rhone-Poulenc Rorer is a global pharmaceutical company based in Collegeville.
 /delval/
 -0- 1/28/93
 /CONTACT: Don Hyman of Miles, 203-498-6545, or Bob Pearson of Rhone-Poulenc Rorer, 215-454-3872/
 (RPR)


CO: Rhone-Poulenc Rorer Inc.; Miles Inc. ST: Pennsylvania IN: MTC SU:

MP -- PH012 -- 0150 01/28/93 10:31 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 28, 1993
Words:125
Previous Article:STANDARD & POOR'S STOCK PRICE INDEX -- OPENING, THURSDAY, JAN. 28 /PRN/
Next Article:EMPLOYMENT COST INDEX FOR THE WEST -- DECEMBER 1992
Topics:


Related Articles
RHONE-POULENC RORER RESTATES COMMITMENT TO HEMOPHILIA COMMUNITY FOR UNINTERRUPTED SUPPLY OF FACTOR VIII:C
MARION MERRELL DOW AND RHONE-POULENC RORER REACH AGREEMENT TO SETTLE DISPUTES REGARDING ANTIHYPERTENSIVE DRUGS
COURT DENIES REQUEST FOR PRELIMINARY PATENT INJUNCTION AGAINST HIGHLY PURIFIED FACTOR VIII:C PRODUCT
RHONE-POULENC PURCHASING SHARES OF RHONE-POULENC RORER TO OFFSET DILUTIVE EVENTS
RHONE-POULENC RORER FILES LAWSUIT AGAINST MARION MERRELL DOW ALLEGING FALSE AND MISLEADING PROMOTION
EUROPEAN PATENT OFFICE UPHOLDS SCRIPPS PATENT FOR ULTRA-PURIFIED FACTOR VIII:C
GENETICS INSTITUTE PLEASED WITH BAXTER AND RHONE-POULENC RORER FACTOR VIII PATENT SETTLEMENT
BAXTER, RHONE-POULENC RORER RESOLVE ALL DISPUTES INVOLVING FACTOR VIII:C PATENTS; SIGN PURCHASING AGREEMENT FOR BAXTER PRODUCTS
RHONE-POULENC RORER S.A. FILES PATENT INFRINGEMENT LAWSUIT AGAINST BRISTOL-MYERS SQUIBB REGARDING TAXOL(R)
Rhone-Poulenc S.A. Successfully Completes Tender Offer For Rhone-Poulenc Rorer Inc.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters